Daiichi Sankyo and Ranbaxy to leverage synergies in Thailand
16 January 2013 | By Daiichi Sankyo
Daiichi Sankyo and Ranbaxy announced their intention to integrate their business operations in Thailand...
List view / Grid view
16 January 2013 | By Daiichi Sankyo
Daiichi Sankyo and Ranbaxy announced their intention to integrate their business operations in Thailand...
16 January 2013 | By Biogen Idec
Biogen Idec and Elan have submitted applications to the U.S. FDA...
16 January 2013 | By Boehringer Ingelheim
The acceptance of the NDA filing reinforces our ongoing commitment to oncology..."
16 January 2013 | By Amgen
Amgen announced plans to build a new manufacturing facility in the Tuas Biomedical Park area of Singapore...
15 January 2013 | By AstraZeneca
AstraZeneca unveiled changes to its executive leadership team...
15 January 2013 | By Daiichi Sankyo
“We are encouraged by these findings..."
15 January 2013 | By Roche
John C. Reed, M.D., Ph.D., has been appointed Head of Roche pRED and member of the enlarged Corporate Executive Committee...
15 January 2013 | By Phenomenex
“The Kinetex product line spans our customers’ needs..."
14 January 2013 | By H. Lundbeck A/S
Lundbeck took first place in a global survey, in which 600 patient groups around the world evaluated the ability of 29 pharmaceutical companies to meet patient expectations...
14 January 2013 | By Novartis
Findings from a pivotal Phase III clinical trial...
14 January 2013 | By GlaxoSmithKline
Albiglutide is not yet approved as a treatment for type 2 diabetes...
Thermo Fisher Scientific Inc.,the world leader in serving science, announced that the United States Pharmacopeial Convention (USP) has selected its Thermo Scientific TruScan RM and microPHAZIR RX instruments to support its recent initiative to provide USP-approved libraries to pharmaceutical manufacturers.
14 January 2013 | By Pfizer
Quillivant XR™ CII for extended-release oral suspension is now available...
11 January 2013 | By Johnson & Johnson
Janssen announced that the EC has approved an extension to the license of the oral, once-daily medication ZYTIGA®...
11 January 2013 | By Merck
Merck is taking steps to suspend the availability of TREDAPTIVE™ tablets worldwide...